Experienced in Autosomal Recessive Cutis Laxa Type 1

Dr. John M. Humeniuk

Dermatology
21 Memorial Medical Dr, 
Greenville, SC 
Experienced in Autosomal Recessive Cutis Laxa Type 1
21 Memorial Medical Dr, 
Greenville, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Humeniuk is a Dermatologist in Greenville, South Carolina. Dr. Humeniuk is rated as an Experienced provider by MediFind in the treatment of Autosomal Recessive Cutis Laxa Type 1. His top areas of expertise are Liver Spots, Universal Acquired Melanosis, Female Pattern Baldness, and Malignant Hypertension.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Procedural Dermatology in SC
Hospital Affiliations
St Francis-Downtown
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Hawaii Medical Assurance Association
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetLife
  • PPO
Nippon Life
  • INSURANCE PLAN
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

21 Memorial Medical Dr, Greenville, SC 29605

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials
Similar Doctors
Experienced in Autosomal Recessive Cutis Laxa Type 1
Dr. Elizabeth S. Dunlavey
Dermatology
Experienced in Autosomal Recessive Cutis Laxa Type 1
Dr. Elizabeth S. Dunlavey
Dermatology

Spartanburg Dermatology And Skin Surgery Clinic, PC

2020 N Church Pl, 
Spartanburg, SC 
 (29.3 miles away)
864-582-3447
Languages Spoken:
English
See accepted insurances

Elizabeth Dunlavey is a Dermatologist in Spartanburg, South Carolina. Dr. Dunlavey is rated as an Advanced provider by MediFind in the treatment of Autosomal Recessive Cutis Laxa Type 1. Her top areas of expertise are Seborrheic Keratosis, Warts, Actinic Keratosis, and Molluscum Contagiosum.

Experienced in Autosomal Recessive Cutis Laxa Type 1
Dr. Michael D. Cogburn
Dermatology
Experienced in Autosomal Recessive Cutis Laxa Type 1
Dr. Michael D. Cogburn
Dermatology
78 Long Shoals Rd, 
Arden, NC 
 (46.6 miles away)
828-684-0703
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Cogburn is a Dermatologist in Arden, North Carolina. Dr. Cogburn is rated as an Advanced provider by MediFind in the treatment of Autosomal Recessive Cutis Laxa Type 1. His top areas of expertise are Malignant Hypertension, Female Pattern Baldness, Actinic Keratosis, and Granuloma Annulare. Dr. Cogburn is currently accepting new patients.

Experienced in Autosomal Recessive Cutis Laxa Type 1
Dr. Camille M. Mason
Dermatology
Experienced in Autosomal Recessive Cutis Laxa Type 1
Dr. Camille M. Mason
Dermatology

Camille Mason MD PA

2526 Hwy 72 E, 
Abbeville, SC 
 (43.7 miles away)
864-227-2822
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Camille Mason is a Dermatologist in Abbeville, South Carolina. Dr. Mason is rated as a Distinguished provider by MediFind in the treatment of Autosomal Recessive Cutis Laxa Type 1. Her top areas of expertise are Actinic Keratosis, Kaposiform Hemangioendothelioma, Fetal Cystic Hygroma, and Hemangioendothelioma. Dr. Mason is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Humeniuk's expertise for a condition
ConditionClose
    View All 22 Distinguished Conditions
    View All 28 Advanced Conditions
    View All 80 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile